Venture Capital Investors

Sofinnova Ventures

Sofinnova Ventures is a VC fund that invests in companies focused on high-impact, technology-driven solutions.

Venture Investor Overview

Venture Investor
Sofinnova Ventures
Status
Active
Investor Type
Venture Capital
Activity Level
241 transaction
Funds Raised
At least $3.1 billion
Industry Focus
Advanced Materials
Biopharmaceutical
Healthcare IT
Healthcare Services
Life Sciences

Contact Information

Contact
James Healy
Title
General Partner
Mailing Address
3000 Sand Hill Rd. Bldg 4 - 250
Menlo Park, CA 94025
USA
Phone
(650) 681-8420
Website
www.sofinnova.com
Email Address
[email protected]

Background Information

Overview
Since 1974, Sofinnova Ventures has partnered with entrepreneurs to secure initial funding, build successful management teams, form impactful corporate alliances, win key customers, and navigate acquisitions and IPOs. Our firm applies capital and expertise to guide start-up companies to successful exits.
Profile
Sofinnova Ventures LinkedIn Company Profile
Social Media
Sofinnova Ventures Company Twitter Account
Company News
Sofinnova Ventures News
Facebook
Sofinnova Ventures on Facebook
YouTube
Sofinnova Ventures on YouTube
Last Transaction
4/10/2024

Transaction History

Our records indicate that Sofinnova Ventures invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Seaport Therapeutics
4/10/2024
$100,000,000
Aeovian Pharmaceuticals
3/29/2024
$50,000,000
Capstan Therapeutics
3/21/2024
$175,000,000
BioAge Labs
2/13/2024
$170,000,000
Rapport Therapeutics
8/23/2023
$150,000,000
Alkeus Pharmaceuticals
6/5/2023
$150,000,000
Quanta Therapeutics
5/22/2023
$50,700,000
Antiva Biosciences
4/27/2023
$53,000,000
Prometheus Materials
6/6/2022
$8,000,000
DMC Bio
12/6/2021
$34,000,000
HotSpot Therapeutics
11/30/2021
$100,000,000
Synthace
11/22/2021
$35,000,000
Mozart Therapeutics
10/30/2021
$55,000,000
XyloCor Therapeutics
3/24/2021
$41,900,000
Vera Therapeutics
1/22/2021
$80,000,000
Atsena Therapeutics
12/17/2020
$55,000,000
Catamaran Bio
11/24/2020
$42,000,000
Aerovate Therapeutics
8/7/2020
$72,600,000
VelosBio
7/9/2020
$137,000,000
Bolt Biotherapeutics
7/2/2020
$93,500,000
Checkmate Pharmaceuticals
6/11/2020
$85,000,000
Protera
6/11/2020
$5,600,000
Athira Pharma
6/5/2020
$85,000,000
HotSpot Therapeutics
5/22/2020
$65,000,000
Amplyx Pharmaceuticals
5/20/2020
$53,000,000
CorVent Medical
5/12/2020
$4,500,000
Nitrome Biosciences
4/23/2020
$38,000,000
RefleXion Medical
4/17/2020
$100,000,000
Akouos
3/4/2020
$105,000,000
IntrepidaBio
10/23/2019
$9,500,000
Aeovian Pharmaceuticals
10/4/2019
$37,000,000
DMC Bio
7/15/2019
$10,300,000
Comet Therapeutics
6/20/2019
$28,500,000
CinCor Pharma
5/15/2019
$50,000,000
Twentyeight-Seven Therapeutics
5/10/2019
$15,000,000
Inozyme Pharma
4/11/2019
$67,000,000
Karuna Therapeutics
4/2/2019
$12,000,000
XyloCor Therapeutics
12/7/2018
$17,000,000
NextCure
11/14/2018
$93,000,000
InCarda Therapeutics
11/9/2018
$42,000,000
Inspirna
10/10/2018
$40,000,000
Galera Therapeutics
9/21/2018
$150,000,000
Akouos
8/8/2018
$50,000,000
HotSpot Therapeutics
7/18/2018
$45,000,000
Antiva Biosciences
7/12/2018
$15,000,000
BioClin Therapeutics
5/10/2018
$50,000,000
Neurana Pharmaceuticals
5/8/2018
$60,000,000
Corvidia Therapeutics
4/26/2018
$60,000,000
RefleXion Medical
4/6/2018
$100,000,000
Pionyr Immunotherapeutics
12/14/2017
$62,000,000
YmAbs Therapeutics
11/30/2017
$30,000,000
Medeor Therapeutics
11/28/2017
$57,000,000
Apellis Pharmaceuticals
8/11/2017
$60,000,000
Checkmate Pharmaceuticals
6/17/2017
$27,000,000
Iterum Therapeutics
5/20/2017
$65,000,000
Sienna Biopharmaceuticals
4/26/2017
$40,000,000
Antiva Biosciences
3/29/2017
$22,000,000
BioClin Therapeutics
3/23/2017
$30,000,000
Breath Therapeutics
3/9/2017
$45,803,107
Galera Therapeutics
11/29/2016
$15,000,000
Shockwave Medical
11/23/2016
$45,000,000
CorWave
11/8/2016
$17,100,000
Delinia
9/15/2016
$35,000,000
Inspirna
6/16/2016
$33,000,000
RefleXion Medical
4/14/2016
$52,000,000
Dauntless 1
3/31/2016
$8,000,000
Checkmate Pharmaceuticals
3/31/2016
$9,970,000
Iterum Therapeutics
3/25/2016
$40,000,000
Corvidia Therapeutics
2/18/2016
$26,000,000
NextCure
1/7/2016
$67,000,000
First Aid Shot Therapy
11/18/2015
$24,000,000
Audentes Therapeutics
10/14/2015
$65,000,000
Checkmate Pharmaceuticals
8/13/2015
$20,000,000
Antiva Biosciences
8/7/2015
$16,000,000
Dauntless Pharmaceuticals
7/22/2015
$12,000,000
Recor Medical
6/30/2015
$15,000,000
Hera Therapeutics
6/30/2015
$6,500,000
Crocus Technology
6/17/2015
$21,000,000
Shockwave Medical
5/19/2015
$40,000,000
Mirna Therapeutics
4/30/2015
$41,800,000
Edge Therapeutics
4/9/2015
$56,000,000
Natera
4/6/2015
$55,500,000
aTyr Pharma
4/1/2015
$76,000,000
Vestagen Protective Technologies
3/31/2015
$800,000
Castle Biosciences
3/31/2015
$2,076,000
Trice Medical
3/31/2015
$18,094,000
Chiasma
2/27/2015
$70,000,000
Principia Biopharma
12/31/2014
$25,300,000
Cebix
12/31/2014
$2,288,000
Audentes Therapeutics
12/3/2014
$42,500,000
Aclaris Therapeutics
10/2/2014
$21,000,000
Civitas Therapeutics
8/25/2014
$55,000,000
Guavus
8/21/2014
$20,000,000
Histogenics
6/30/2014
$5,225,000
Spark Therapeutics
5/28/2014
$72,800,000
Coherus BioSciences
5/19/2014
$55,000,000
Sorbent Therapeutics
5/15/2014
$6,500,000
Principia Biopharma
4/22/2014
$50,000,000
RefleXion Medical
4/5/2014
$11,600,000
Cebix
3/31/2014
$6,000,000
Coherus BioSciences
3/31/2014
$5,225,000
ZS Pharma
3/6/2014
$55,000,000
Versartis
2/18/2014
$55,000,000
First Aid Shot Therapy
2/10/2014
Unknown
Shockwave Medical
1/29/2014
$12,500,000
Mirna Therapeutics
12/31/2013
$4,750,000
Green Biologics
12/5/2013
$25,000,000
Versartis
10/8/2013
$20,000,000
Crocus Technology
7/11/2013
$45,000,000
First Aid Shot Therapy
5/22/2013
Unknown
Sorbent Therapeutics
3/31/2013
$2,533,000
ConteXtream
3/31/2013
$217,000
Marinus Pharmaceuticals
3/31/2013
$9,564,000
Guavus
1/10/2013
$30,000,000
Labrys Biologics
1/4/2013
$31,000,000
CrestaTech
12/31/2012
$1,385,000
Histogenics
12/31/2012
$150,400
Marinus Pharmaceuticals
12/18/2012
$21,000,000
Flexion Therapeutics
12/4/2012
$20,000,000
Aclaris Therapeutics
10/25/2012
$21,000,000
Mirna Therapeutics
10/24/2012
$34,500,000
Cebix
10/18/2012
$30,900,000
Histogenics
7/24/2012
$49,000,000
CrestaTech
5/1/2012
$13,000,000
Durata Therapeutics
3/31/2012
$22,000,000
Mainstay Medical
12/31/2011
$700,000
Laszlo Systems
12/31/2011
$2,200,000
Laszlo Systems
9/30/2011
$800,000
Durata Therapeutics
9/30/2011
$22,000,000
SARCode Bioscience
7/18/2011
$44,000,000
SpineVision
7/6/2011
$5,000,000
Laszlo Systems
6/30/2011
$1,400,000
Sorbent Therapeutics
6/30/2011
$36,000,000
BioAmber
5/4/2011
$45,000,000
Durata Therapeutics
3/31/2011
$4,396,000
Omthera Pharmaceuticals
3/14/2011
$33,900,000
ConteXtream
11/2/2010
$14,000,379
ASSIA
10/26/2010
$20,800,000
CrestaTech
9/30/2010
$3,062,000
Sorbent Therapeutics
9/13/2010
$21,800,000
Sorbent Therapeutics
6/30/2010
$3,992,000
Hyperion Therapeutics
6/30/2010
$22,431,000
Vicept Therapeutics
6/30/2010
$10,000,000
KXEN
6/16/2010
$8,000,000
MXP4
4/22/2010
$4,000,000
Entourage Medical Technologies
3/31/2010
$1,500,000
Alvine Pharmaceuticals
3/31/2010
$2,559,000
Omthera Pharmaceuticals
3/8/2010
$6,500,000
UPEK
12/31/2009
$6,157,000
BioAmber
10/27/2009
$12,000,000
Flexion Therapeutics
10/16/2009
$33,000,000
Vicept Therapeutics
9/30/2009
$6,000,000
Guavus
9/30/2009
$1,750,000
Alvine Pharmaceuticals
9/15/2009
$21,500,000
Hyperion Therapeutics
7/5/2009
$60,000,000
NextWave Pharmaceuticals
6/30/2009
$6,917,000
Cebix
6/30/2009
$2,276,000
UPEK
6/30/2009
Unknown
Stentys
6/29/2009
$4,200,000
CoAxia
6/23/2009
$21,500,000
Streamezzo
5/13/2009
$5,100,000
Marinus Pharmaceuticals
4/10/2009
$20,000,000
InteKrin Therapeutics
3/31/2009
$927,000
Intellikine
3/31/2009
$4,117,000
KaloBios Pharmaceuticals
12/22/2008
$12,000,000
Cebix
10/31/2008
$2,850,000
Crocus Technology
10/6/2008
$15,800,000
ENOVIX
9/30/2008
$11,999,900
Laszlo Systems
9/30/2008
$2,052,000
Anthera Pharmaceuticals
8/14/2008
$19,000,000
InteKrin Therapeutics
8/4/2008
$18,250,000
Alvine Pharmaceuticals
3/31/2008
$11,500,000
CrestaTech
3/31/2008
$7,000,000
Ascenta Therapeutics
3/31/2008
$20,000,000
Laszlo Systems
3/5/2008
$6,600,000
Ocera Therapeutics
2/20/2008
$35,500,000
Catalyst Biosciences
12/31/2007
$13,480,000
Anza Therapeutics
12/31/2007
$18,000,000
Fovea Pharmaceuticals
12/13/2007
$44,000,000
INSIDE Secure
12/11/2007
$38,000,000
Calient Technologies
11/2/2007
$10,000,000
Catalyst Mobile
10/9/2007
$10,000,000
Phenomix
9/30/2007
$27,499,600
Hyperion Therapeutics
9/5/2007
$40,000,000
OVATION Pharmaceuticals
8/27/2007
$20,000,000
KaloBios Pharmaceuticals
7/23/2007
$20,000,000
ConteXtream
7/20/2007
$9,600,000
UPEK
6/30/2007
$7,000,000
Tensys Medical
6/30/2007
$5,700,000
DiObex
4/16/2007
$24,000,000
Ascenta Therapeutics
4/9/2007
$50,000,000
CoreValve
3/28/2007
$33,000,000
Phenomix
3/8/2007
$55,000,000
Trius Therapeutics
2/27/2007
$20,000,000
Narad Networks
2/22/2007
$10,000,000
NextWave Pharmaceuticals
2/14/2007
$40,000,000
InteKrin Therapeutics
1/11/2007
$23,000,000
Sequoia Pharmaceuticals
1/9/2007
$35,000,000
Orexigen Therapeutics
11/22/2006
$30,000,000
Cerenis Therapeutics
11/13/2006
$53,500,000
Anthera Pharmaceuticals
9/13/2006
$36,000,000
Alvine Pharmaceuticals
9/12/2006
$21,000,000
Laszlo Systems
9/6/2006
$8,000,000
INSIDE Secure
9/5/2006
$25,000,000
Ablynx
8/23/2006
$50,000,000
OVATION Pharmaceuticals
7/24/2006
$60,000,000
Ocera Therapeutics
7/11/2006
$12,000,000
UPEK
6/30/2006
$8,000,100
Crocus Technology
6/15/2006
$17,000,000
Sorbent Therapeutics
3/31/2006
$19,200,000
Network Physics
3/31/2006
$8,627,000
Phenomix
3/31/2006
$20,005,100
Catalyst Biosciences
2/9/2006
$30,000,000
DBV Technologies
1/23/2006
$15,044,200
Transcept Pharmaceuticals
1/4/2006
$25,000,000
SpineVision
12/6/2005
$16,000,000
Fovea Pharmaceuticals
11/7/2005
$25,000,000
Ascenta Therapeutics
11/5/2005
$30,000,000
Reef Point Systems
6/30/2005
$8,203,200
Orexigen Therapeutics
6/30/2005
$35,000,000
HelloSoft
6/21/2005
$16,000,000
Phenomix
5/24/2005
$40,000,000
Laszlo Systems
4/12/2005
$6,250,000
UPEK
3/31/2005
$9,300,000
Corente
3/31/2005
$1,900,000
OVATION Pharmaceuticals
12/6/2004
$37,000,000
Catalyst Biosciences
12/4/2004
$40,000,000
Ascenta Therapeutics
11/5/2004
$5,500,000
Intransa
9/16/2004
$25,000,000
Calient Technologies
4/26/2004
$35,000,000
UPEK
3/17/2004
$20,000,000
WebDialogs
1/21/2004
$1,900,000
Threshold Pharmaceuticals
1/12/2004
$41,000,000
Transcept Pharmaceuticals
1/8/2004
$35,000,000
Intransa
1/5/2004
$8,000,000
CoTherix
10/14/2003
$55,000,000
Phenomix
10/14/2003
$35,500,000
OVATION Pharmaceuticals
6/19/2003
$15,000,000
Cellzome AG
3/18/2003
$38,330,400
HelloSoft
1/28/2003
$11,000,000
Narad Networks
1/12/2003
$17,500,000

 

Investor Contacts

Title
Name
Email & Social
General Partner
Srinivas Akkaraju
  Srinivas Akkaraju LinkedIn Profile  Srinivas Akkaraju Twitter Account  Srinivas Akkaraju News  Srinivas Akkaraju on Facebook
Partner
Sarah Bhagat
  Sarah Bhagat LinkedIn Profile  Sarah Bhagat Twitter Account  Sarah Bhagat News  Sarah Bhagat on Facebook
Partner
Maina Bhaman
  Maina Bhaman LinkedIn Profile  Maina Bhaman Twitter Account  Maina Bhaman News  Maina Bhaman on Facebook
General Partner
James Healy
  James Healy LinkedIn Profile  James Healy Twitter Account  James Healy News  James Healy on Facebook
General Partner
Maha Katabi
  Maha Katabi LinkedIn Profile  Maha Katabi Twitter Account  Maha Katabi News  Maha Katabi on Facebook
Partner
Anand Mehra
  Anand Mehra LinkedIn Profile  Anand Mehra Twitter Account  Anand Mehra News  Anand Mehra on Facebook
General Partner
Michael Powell
  Michael Powell LinkedIn Profile  Michael Powell Twitter Account  Michael Powell News  Michael Powell on Facebook

 

Funds

Our database includes the following fund closing(s) for Sofinnova Ventures. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
Sofinnova Crossover I
4/4/2018
$340,000,000
Sofinnova BioEquities
5/16/2017
$10,345,000
Sofinnova Industrial Biotech I
3/2/2017
$111,000,000
Sofinnova Venture Partners X
8/24/2016
$650,000,000
Sofinnova Capital VIII
12/8/2015
$325,400,000
Sofinnova Venture Partners IX
7/23/2014
$500,000,000
Sofinnova HealthQuest Partners
6/30/2013
$110,000,000
Sofinnova Venture Partners VIII
10/17/2011
$440,000,000
Sofinnova Venture Partners VII
8/15/2006
$375,000,000
Sofinnova Venture Partners VI
1/1/2002
$250,000,000

 

Portfolio Companies

Sofinnova Ventures has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Ablynx
Aclaris Therapeutics
Aeovian Pharmaceuticals
Aerovate Therapeutics
Akouos
Alkeus Pharmaceuticals
Alvine Pharmaceuticals
Amplyx Pharmaceuticals
Anthera Pharmaceuticals
Antiva Biosciences
Anza Therapeutics
Apellis Pharmaceuticals
Ascenta Therapeutics
ASSIA
Athira Pharma
Atsena Therapeutics
aTyr Pharma
Audentes Therapeutics
BioAge Labs
BioAmber
BioClin Therapeutics
Bolt Biotherapeutics
Breath Therapeutics
Calient Technologies
Capstan Therapeutics
Castle Biosciences
Catalyst Biosciences
Catalyst Mobile
Catamaran Bio
Cebix
Cellzome AG
Cerenis Therapeutics
Checkmate Pharmaceuticals
Chiasma
CinCor Pharma
Civitas Therapeutics
CoAxia
Coherus BioSciences
Comet Therapeutics
ConteXtream
Corente
CoreValve
CorVent Medical
Corvidia Therapeutics
CorWave
CoTherix
CrestaTech
Crocus Technology
Dauntless 1
Dauntless Pharmaceuticals
DBV Technologies
Delinia
DiObex
DMC Bio
Durata Therapeutics
Edge Therapeutics
ENOVIX
Entourage Medical Technologies
First Aid Shot Therapy
Flexion Therapeutics
Fovea Pharmaceuticals
Galera Therapeutics
Green Biologics
Guavus
HelloSoft
Hera Therapeutics
Histogenics
HotSpot Therapeutics
Hyperion Therapeutics
InCarda Therapeutics
Inozyme Pharma
INSIDE Secure
Inspirna
InteKrin Therapeutics
Intellikine
Intransa
IntrepidaBio
Iterum Therapeutics
KaloBios Pharmaceuticals
Karuna Therapeutics
KXEN
Labrys Biologics
Laszlo Systems
Mainstay Medical
Marinus Pharmaceuticals
Medeor Therapeutics
Mirna Therapeutics
Mozart Therapeutics
MXP4
Narad Networks
Natera
Network Physics
Neurana Pharmaceuticals
NextCure
NextWave Pharmaceuticals
Nitrome Biosciences
Ocera Therapeutics
Omthera Pharmaceuticals
Orexigen Therapeutics
OVATION Pharmaceuticals
Phenomix
Pionyr Immunotherapeutics
Principia Biopharma
Prometheus Materials
Protera
Quanta Therapeutics
Rapport Therapeutics
Recor Medical
Reef Point Systems
RefleXion Medical
SARCode Bioscience
Seaport Therapeutics
Sequoia Pharmaceuticals
Shockwave Medical
Sienna Biopharmaceuticals
Sorbent Therapeutics
Spark Therapeutics
SpineVision
Stentys
Streamezzo
Synthace
Tensys Medical
Threshold Pharmaceuticals
Transcept Pharmaceuticals
Trice Medical
Trius Therapeutics
Twentyeight-Seven Therapeutics
UPEK
VelosBio
Vera Therapeutics
Versartis
Vestagen Protective Technologies
Vicept Therapeutics
WebDialogs
XyloCor Therapeutics
YmAbs Therapeutics
ZS Pharma

 

 

 

 

Browse more venture capital investors:

Sofinnova Partners | Sofiouest

 

Share this article

 

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.